Завод ДИОД DIOD

Завод ДИОД Kennzahlen 2007-2026 | DIOD

Kennzahlen Jährlich Завод ДИОД

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Price Earnings Ratio, P/E	171.2	17.39	8.02	18.37	6.76	34.25	-17.77	-2.12	-3.2	5.41	-2.3	46.55	11.82	18.46	7.83	0.0	0.0
Price Sales Ratio, P/S	2.63	1.25	1.21	1.32	0.66	0.49	0.56	0.34	0.4	0.24	0.32	0.55	0.97	1.94	1.88	0.0	0.0
Price To Book Ratio, P/B	1.27	0.58	0.59	0.57	0.36	0.32	0.34	0.21	0.25	0.18	0.22	0.35	0.82	1.65	1.71	0.0	0.0
Price Earnings To Growth Ratio, PEG	-2.16	-0.31	0.05	-0.4	0.01	-0.24	0.22	-0.12	0.01	-0.04	0.0	-0.52	-0.55	-0.33	-0.08	-0.0	-
Operating Cash Flow Per Share	0.03	0.0	0.0	0.0	1.85	0.0	0.0	-0.0	-	-	-	-	-	-	-	-	15370.93
Free Cash Flow Per Share	-0.35	0.0	-0.12	-0.01	1.83	-0.17	0.0	-0.0	1.13	0.57	-0.36	-0.02	-0.07	-0.19	-0.24	-3745.79	15117.49
Cash Per Share	0.37	2.29	1.93	1.31	0.33	1.12	0.92	0.99	1.57	0.02	0.15	0.19	0.19	0.42	0.42	3126.89	2527.87
Payout Ratio	8.63	0.0	0.6	1.04	0.6	3.03	-0.0	-0.0	-0.09	0.42	-0.07	1.67	0.42	0.06	0.07	0.04	-
Dividend Yield	0.05	0.0	0.07	0.06	0.09	0.09	0.0	0.0	0.03	0.08	0.03	0.04	0.04	0.0	0.01	45.31	-
Current Ratio	6.72	7.56	9.22	8.75	5.75	5.02	4.95	5.72	3.11	1.82	2.44	3.76	2.94	2.9	1.73	2.44	2.26
Quick Ratio	4.22	4.65	5.61	4.92	3.14	2.67	2.12	2.26	1.26	0.8	1.45	2.4	1.97	1.74	0.84	1.18	1.42
Cash Ratio	0.26	0.87	0.87	0.47	0.03	0.17	0.04	0.06	0.38	0.0	0.02	0.04	0.03	0.08	0.05	0.06	0.06
Days Of Sales Outstanding, DSO	204.37	-	213.41	251.13	239.58	172.78	114.3	110.19	106.68	104.26	213.96	251.45	182.99	192.83	131.91	108.46	123.35
Days Of Inventory Outstanding, DIO	466.79	540.78	545.11	767.96	505.37	477.25	467.31	459.56	800.12	470.68	611.43	517.97	279.75	276.4	321.55	313.16	180.94
Days Of Payables Outstanding, DPO	21.45	21.07	46.49	144.57	141.34	93.18	99.01	39.08	121.37	70.69	55.61	0.34	49.18	17.54	22.52	26.11	11.36
Operating Cycle	671.16	540.78	758.51	1019.1	744.95	650.03	581.61	569.75	906.8	574.94	825.38	769.42	462.73	469.22	453.47	421.62	304.3
Cash Conversion Cycle	649.71	519.71	712.02	874.53	603.61	556.85	482.6	530.67	785.43	504.26	769.77	769.08	413.55	451.68	430.95	395.51	292.93
Gross Profit Margin	0.54	0.57	0.59	0.63	0.54	0.58	0.5	0.45	0.67	0.55	0.65	0.6	0.54	0.51	0.53	0.61	0.58
Operating Profit Margin	0.0	0.08	0.18	0.14	0.15	0.07	-0.06	0.06	0.1	0.14	0.16	0.14	0.19	0.2	0.34	0.26	0.21
Pretax Profit Margin	0.02	0.11	0.19	0.11	0.12	0.06	-0.03	-0.15	-0.11	0.06	-0.12	0.02	0.1	0.11	0.26	0.24	0.21
Net Profit Margin	0.02	0.07	0.15	0.07	0.1	0.01	-0.03	-0.16	-0.12	0.04	-0.14	0.01	0.08	0.11	0.24	0.17	0.14
Effective Tax Rate	0.37	0.29	0.23	0.39	0.19	0.78	0.39	-0.05	-0.13	0.28	-0.15	0.68	0.25	0.21	0.11	0.26	0.3
Return On Assets, ROA	0.01	0.03	0.06	0.03	0.04	0.01	-0.02	-0.08	-0.06	0.02	-0.06	0.0	0.04	0.05	0.12	0.13	0.15
Return On Equity, ROE	0.01	0.03	0.07	0.03	0.05	0.01	-0.02	-0.1	-0.08	0.03	-0.1	0.01	0.07	0.09	0.22	0.22	0.21
Return On Capital Employed, ROCE	0.0	0.03	0.08	0.06	0.08	0.05	-0.03	0.03	0.06	0.1	0.09	0.06	0.1	0.11	0.22	0.24	0.28
Net Income Per Ebt	0.63	0.67	0.79	0.65	0.8	0.23	0.98	1.05	1.13	0.71	1.15	0.54	0.85	0.99	0.91	0.74	0.68
Ebt Per Ebit	7.37	1.33	1.07	0.78	0.81	0.83	0.58	-2.71	-1.15	0.44	-0.75	0.15	0.52	0.55	0.78	0.89	1.01
Ebit Per Revenue	0.0	0.08	0.18	0.14	0.15	0.07	-0.06	0.06	0.1	0.14	0.16	0.14	0.19	0.2	0.34	0.26	0.21
Debt Ratio	-	-	0.03	0.0	0.01	0.05	0.03	0.01	0.01	0.18	0.3	0.3	0.21	0.18	0.17	0.22	0.12
Debt Equity Ratio	-	-	0.04	0.0	0.01	0.06	0.04	0.01	0.01	0.27	0.51	0.52	0.4	0.34	0.31	0.38	0.17
Long Term Debt To Capitalization	-	-	-	-	0.03	0.01	0.01	0.01	0.0	0.0	0.17	0.28	0.2	0.17	0.04	0.18	-
Total Debt To Capitalization	-	-	0.04	0.0	0.01	0.06	0.04	0.01	0.01	0.21	0.34	0.34	0.29	0.25	0.24	0.27	0.14
Interest Coverage	-	1222.43	5633.42	127.13	28.15	-	-1.98	1.33	0.82	1.95	1.83	1.67	3.25	3.23	4.52	10.37	164.81
Cash Flow To Debt Ratio	-	-	0.0	0.07	21.21	0.0	0.0	-0.0	-	-	-	-	-	-	-	-	0.77
Company Equity Multiplier	1.19	1.17	1.15	1.16	1.2	1.21	1.21	1.19	1.31	1.5	1.7	1.72	1.96	1.84	1.81	1.72	1.45
Receivables Turnover	1.79	-	1.71	1.45	1.52	2.11	3.19	3.31	3.42	3.5	1.71	1.45	1.99	1.89	2.77	3.37	2.96
Payables Turnover	17.01	17.32	7.85	2.52	2.58	3.92	3.69	9.34	3.01	5.16	6.56	1063.66	7.42	20.81	16.21	13.98	32.12
Inventory Turn Over	0.78	0.67	0.67	0.48	0.72	0.76	0.78	0.79	0.46	0.78	0.6	0.7	1.3	1.32	1.14	1.17	2.02
Fixed Asset Turnover	2.2	2.16	2.23	1.93	2.39	3.12	3.12	3.28	3.42	4.38	3.74	3.62	3.17	3.42	3.52	4.31	4.23
Asset Turnover	0.41	0.4	0.42	0.37	0.45	0.54	0.51	0.53	0.47	0.51	0.41	0.37	0.43	0.46	0.5	0.74	1.03
Operating Cash Flow Sales Ratio	0.01	0.0	0.0	0.0	0.26	0.0	0.0	-0.0	-	-	-	-	-	-	-	-	0.09
Free Cash Flow Operating Cash Flow Ratio	-10.39	0.97	-103.26	-10.64	0.99	-295.91	0.62	1.02	-	-	-	-	-	-	-	-	0.98
Cash Flow Coverage Ratios	-	-	0.0	0.07	21.21	0.0	0.0	-0.0	-	-	-	-	-	-	-	-	0.77
Short Term Coverage Ratios	-	-	0.02	0.07	21.21	0.0	0.0	-0.01	-	-	-	-	-	-	-	-	0.77
Capital Expenditure Coverage Ratio	0.09	36.09	0.01	0.09	83.3	0.0	2.61	-41.64	-	-	-	-	-	-	-	-	60.65
Dividend Paid And Capex Coverage Ratio	0.03	1.38	0.0	0.0	4.18	0.0	1.19	-41.22	-	-	-	-	-	-	-	-	60.65
Dividend Payout Ratio	8.63	0.0	0.6	1.04	0.6	3.03	-0.0	-0.0	-0.09	0.42	-0.07	1.67	0.42	0.06	0.07	0.04	-
Price To Free Cash Flows Ratio, P/FCF	-45.1	7196.53	-67.86	-719.95	2.58	-24.09	9568.71	-3567.51	3.71	5.91	-10.84	-387.96	-232.77	-171.45	-132.63	-0.01	0.0
Price To Operating Cash Flows Ratio, P/OCF	468.51	6997.11	7007.48	7657.5	2.55	7128.65	5897.15	-3653.19	-	-	-	-	-	-	-	-	0.0
Price Cash Flow Ratio, P/CF	468.51	6997.11	7007.48	7657.5	2.55	7128.65	5897.15	-3653.19	-	-	-	-	-	-	-	-	0.0
Enterprise Value Multiple, EV	62.85	9.12	5.22	8.22	4.02	4.62	14.36	-4.61	20.81	4.11	186.13	10.26	8.9	13.84	6.0	1.08	0.44
Price Fair Value, P/FV	1.27	0.58	0.59	0.57	0.36	0.32	0.34	0.21	0.25	0.18	0.22	0.35	0.82	1.65	1.71	0.0	0.0

Alle Zahlen in RUB-Währung

Kennzahlen Vierteljährlich Завод ДИОД

	2023-Q2	2022-Q4	2022-Q2	2021-Q4	2021-Q2	2020-Q4	2020-Q2	2019-Q4	2019-Q2	2018-Q4	2018-Q2	2017-Q4	2017-Q2	2016-Q4	2016-Q2	2015-Q4	2015-Q2	2014-Q4	2014-Q2	2013-Q4	2013-Q2	2011-Q4	2011-Q2	2010-Q4	2010-Q2	2009-Q4	2009-Q2	2008-Q4	2008-Q2
Price Earnings Ratio, P/E	69.1	6.56 K	12	6.38	3.72	5.6	15.9	14.3	1.99	-10.2	5.66	-1.93	2.64	-2.18	-0.813	-1.21	-2.36	2.7	3.38	8.69	-1.13	5.91	8.06	9.23	8.68	3.92	3.92	0.001	0.0
Price Sales Ratio, P/S	4.24	2.7 K	2.47	2.48	3	2.19	2.35	1.35	1.35	0.987	1.18	1.26	0.795	0.723	0.733	0.7	0.93	0.482	0.603	0.565	1.51	1.95	2.66	3.88	3.64	3.76	3.76	0.0	0.0
Price To Book Ratio, P/B	1.01	0.582	0.632	0.588	0.767	0.541	0.419	0.357	0.379	0.322	0.346	0.345	0.256	0.211	0.239	0.247	0.236	0.184	0.236	0.222	0.229	0.816	1.12	1.65	1.6	1.71	1.9	-	0.0
Price Earnings To Growth Ratio, PEG	0.003	-65.7	-0.265	-0.117	0.033	0.022	1.75	-0.165	-0.003	0.07	-0.043	0.007	-0.013	0.032	-0.023	-0.013	0.01	-	0.019	-0.077	0.001	-	-0.377	-	-0.154	-	-0.039	-	-0.0
Operating Cash Flow Per Share	0.017	0.0	0.72	0.405	0.762	0.627	0.342	0.491	1.39	0.56	-	0.001	-0.0	-0.0	-0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow Per Share	-0.175	0.0	0.711	0.344	0.704	0.616	0.342	0.541	1.31	0.528	-0.087	0.001	-0.0	-0.0	-0.0	0.566	0.566	0.286	0.286	-0.182	-0.182	-0.035	-0.035	-0.096	-0.096	-0.121	-0.121	-936	-1.87 K
Cash Per Share	2.52	2.3	2.66	1.93	2.12	1.37	0.699	0.334	1.4	1.11	1.04	0.921	1.03	0.991	1.38	1.57	0.046	0.02	0.161	0.154	0.228	0.189	0.302	0.415	0.418	0.42	0.367	-	2.83 K
Payout Ratio	8.63	2.62	0.0	1.88	0.005	1.33	-	5.13	0.17	-3.56	0.819	-0.001	-	-0.0	-	-0.068	-0.133	0.425	0.425	0.538	-0.067	0.422	0.422	0.063	0.063	0.065	0.065	0.029	0.044
Dividend Yield	0.031	0.0	0.0	0.074	0.0	0.059	-	0.089	0.021	0.088	0.036	0.0	-	0.0	-	0.014	0.014	0.039	0.031	0.015	0.015	0.018	0.013	0.002	0.002	0.004	0.004	11.3	22.7
Current Ratio	5	7.56	5.58	9.22	5.84	8.75	6.53	5.75	5.24	5.02	4.52	4.95	4.2	5.72	2.55	3.11	1.88	1.82	1.88	2.44	3.06	2.94	2.92	2.9	2.21	1.73	2.01	-	2.35
Quick Ratio	3.23	4.65	3.41	5.61	3.51	4.92	3.69	3.14	2.63	2.67	2.1	2.12	2.02	2.26	1.31	1.26	0.714	0.796	1.08	1.45	1.83	1.97	1.87	1.74	1.21	0.838	0.972	-	1.29
Cash Ratio	0.643	0.874	0.839	0.872	0.643	0.474	0.231	0.025	0.305	0.166	0.088	0.041	0.055	0.061	0.087	0.385	0.007	0.002	0.019	0.021	0.037	0.031	0.052	0.077	0.063	0.054	0.057	-	0.06
Days Of Sales Outstanding, DSO	-	126 K	89	108	105	117	139	121	74.6	85.7	62.6	62.8	71.8	58.3	101	46.2	65	-	-	-	-	90.2	92.6	95.1	80.3	65.1	62.2	-	55.3
Days Of Inventory Outstanding, DIO	240	274 K	255	239	311	318	476	324	222	226	291	245	230	241	231	272	487	232	187	259	743	138	141	136	145	159	151	-	122
Days Of Payables Outstanding, DPO	37.9	10.7 K	12.3	20.4	10.9	59.9	74.2	90.6	13.5	44.1	15.2	52	30	20.5	115	41.3	84.9	34.9	26	23.5	97.9	24.3	16.7	8.65	9.68	11.1	11.5	-	9.25
Operating Cycle	240	401 K	344	347	416	436	615	445	296	312	354	308	302	300	331	319	552	232	187	259	743	228	234	231	225	224	213	-	177
Cash Conversion Cycle	202	390 K	332	326	405	376	540	354	283	267	339	256	272	279	217	277	467	197	161	235	645	204	217	223	215	213	202	-	168
Gross Profit Margin	0.536	0.547	0.566	0.53	0.632	0.618	0.642	0.642	0.437	0.555	0.596	0.478	0.52	0.448	0.455	0.584	0.668	0.546	0.546	0.635	0.665	0.541	0.541	0.514	0.514	0.534	0.534	0.583	0.611
Operating Profit Margin	0.003	0.108	0.061	0.056	0.242	0.131	0.04	0.073	0.083	0.015	0.13	-0.19	0.053	-0.026	0.127	0.165	0.003	0.143	0.143	0.145	0.182	0.188	0.188	0.195	0.195	0.336	0.336	0.205	0.264
Pretax Profit Margin	0.024	0.126	0.09	0.119	0.258	0.141	0.069	0.089	0.155	0.045	0.075	-0.176	0.084	-0.039	-0.25	-0.059	-0.177	0.063	0.063	0.034	-0.317	0.097	0.097	0.107	0.107	0.263	0.263	0.206	0.236
Net Profit Margin	0.015	0.103	0.052	0.097	0.202	0.098	0.037	0.023	0.169	-0.024	0.052	-0.163	0.075	-0.083	-0.225	-0.144	-0.098	0.045	0.045	0.016	-0.335	0.082	0.082	0.105	0.105	0.24	0.24	0.141	0.175
Effective Tax Rate	0.372	0.227	0.375	0.252	0.217	0.369	0.449	0.719	-0.097	1.42	0.401	0.219	0.096	-1.19	0.207	-1.43	0.903	0.281	0.281	0.489	-0.062	0.252	0.252	0.215	0.215	0.112	0.112	0.301	0.259
Return On Assets, ROA	0.003	0.0	0.011	0.02	0.043	0.021	0.006	0.005	0.039	-0.007	0.012	-0.037	0.019	-0.02	-0.051	-0.039	-0.017	0.011	0.011	0.004	-0.03	0.018	0.018	0.024	0.025	0.06	0.069	-	0.077
Return On Equity, ROE	0.004	0.0	0.013	0.023	0.051	0.024	0.007	0.006	0.048	-0.008	0.015	-0.045	0.024	-0.024	-0.073	-0.051	-0.025	0.017	0.017	0.006	-0.051	0.035	0.035	0.045	0.046	0.109	0.121	-	0.123
Return On Capital Employed, ROCE	0.001	0.0	0.015	0.012	0.058	0.03	0.007	0.018	0.022	0.005	0.035	-0.049	0.016	-0.007	0.039	0.054	0.001	0.051	0.049	0.045	0.02	0.048	0.049	0.053	0.058	0.11	0.122	-	0.149
Net Income Per Ebt	0.628	0.815	0.574	0.817	0.781	0.695	0.532	0.264	1.09	-0.538	0.693	0.929	0.896	2.13	0.901	2.44	0.555	0.705	0.705	0.484	1.06	0.851	0.851	0.985	0.985	0.912	0.912	0.684	0.741
Ebt Per Ebit	7.37	1.17	1.47	2.13	1.07	1.07	1.71	1.23	1.88	2.94	0.581	0.923	1.6	1.5	-1.97	-0.359	-56.3	0.442	0.442	0.232	-1.75	0.516	0.516	0.545	0.545	0.783	0.783	1.01	0.894
Ebit Per Revenue	0.003	0.108	0.061	0.056	0.242	0.131	0.04	0.073	0.083	0.015	0.13	-0.19	0.053	-0.026	0.127	0.165	0.003	0.143	0.143	0.145	0.182	0.188	0.188	0.195	0.195	0.336	0.336	0.205	0.264
Debt Ratio	-	-	0.0	0.033	-	0.001	0.029	0.006	0.026	0.05	0.041	0.034	0.023	0.01	0.008	0.011	0.17	0.179	0.238	0.299	0.323	0.205	0.195	0.183	0.177	0.171	0.192	-	0.178
Debt Equity Ratio	-	-	0.0	0.038	-	0.001	0.035	0.007	0.032	0.061	0.05	0.041	0.028	0.012	0.012	0.015	0.248	0.27	0.382	0.507	0.551	0.402	0.37	0.337	0.324	0.31	0.34	-	0.284
Long Term Debt To Capitalization	-	-	-	0.033	-	-	0.027	0.027	0.006	0.006	0.006	0.005	0.005	0.005	0.005	0.005	0.005	0.004	0.06	0.173	0.231	0.199	0.186	0.173	0.115	0.042	0.111	-	0.112
Total Debt To Capitalization	-	-	0.0	0.037	-	0.001	0.034	0.007	0.031	0.057	0.048	0.039	0.028	0.012	0.012	0.014	0.199	0.213	0.276	0.336	0.355	0.287	0.27	0.252	0.245	0.237	0.254	-	0.221
Interest Coverage	-	-	-	28.8	176	-	-	0.055	0.012	-	-	-3	-	-	-	-	-	1.95	1.95	-	-	3.25	3.25	3.23	3.23	4.52	4.52	165	10.4
Cash Flow To Debt Ratio	-	-	1.58 K	0.787	-	47.2	0.723	5.59	3.3	0.725	-	0.002	-0.001	-0.002	-0.002	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Company Equity Multiplier	1.25	1.17	1.22	1.15	1.21	1.16	1.18	1.2	1.21	1.21	1.23	1.21	1.24	1.19	1.43	1.31	1.46	1.5	1.6	1.7	1.71	1.96	1.9	1.84	1.83	1.81	1.77	-	1.6
Receivables Turnover	-	0.001	1.01	0.834	0.855	0.767	0.648	0.745	1.21	1.05	1.44	1.43	1.25	1.54	0.895	1.95	1.38	-	-	-	-	0.997	0.972	0.946	1.12	1.38	1.45	-	1.63
Payables Turnover	2.37	0.008	7.33	4.42	8.25	1.5	1.21	0.994	6.66	2.04	5.9	1.73	3	4.39	0.784	2.18	1.06	2.58	3.46	3.82	0.919	3.71	5.39	10.4	9.3	8.11	7.81	-	9.73
Inventory Turn Over	0.376	0.0	0.353	0.377	0.29	0.283	0.189	0.278	0.406	0.398	0.309	0.367	0.392	0.373	0.39	0.33	0.185	0.388	0.481	0.348	0.121	0.652	0.638	0.66	0.622	0.568	0.596	-	0.737
Fixed Asset Turnover	1.07	0.001	1.15	1.09	1.15	1.11	0.802	1.17	1.3	1.55	1.5	1.4	1.71	1.53	1.71	1.95	1.45	2.19	2.15	2.1	0.804	1.59	1.65	1.71	1.73	1.76	1.85	-	2.2
Asset Turnover	0.191	0.0	0.21	0.207	0.212	0.214	0.151	0.222	0.233	0.27	0.238	0.227	0.259	0.245	0.228	0.269	0.174	0.254	0.245	0.232	0.089	0.214	0.222	0.231	0.24	0.251	0.286	-	0.441
Operating Cash Flow Sales Ratio	0.006	0.149	0.218	0.126	0.226	0.197	0.14	0.14	0.373	0.135	-	0.0	-0.0	-0.0	-0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow Operating Cash Flow Ratio	-10.4	0.95	0.987	0.851	0.924	0.982	1	1.1	0.948	0.942	-	0.757	1.27	1	1.05	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Coverage Ratios	-	-	1.58 K	0.787	-	47.2	0.723	5.59	3.3	0.725	-	0.002	-0.001	-0.002	-0.002	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Coverage Ratios	-	-	-	8.68	-	47.2	3.68	5.59	4.12	0.809	-	0.002	-0.001	-0.004	-0.004	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capital Expenditure Coverage Ratio	0.088	0.02	77.5	6.69	13.2	56.5	-	9.97	19.1	17.1	-	4.11	-3.71	-	-20.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividend Paid And Capex Coverage Ratio	0.029	0.019	77	0.625	12.4	1.47	-	1.04	7.73	1.43	-	1.66	-3.71	-2.06 K	-20.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	8.63	2.62	0.0	1.88	0.005	1.33	-	5.13	0.17	-3.56	0.819	-0.001	-	-0.0	-	-0.068	-0.133	0.425	0.425	0.538	-0.067	0.422	0.422	0.063	0.063	0.065	0.065	0.029	0.044
Price To Free Cash Flows Ratio, P/FCF	-72.8	19.1 K	11.5	23.1	14.4	11.3	16.7	8.75	3.81	7.79	-58.8	6.12 K	-13.2 K	-7.24 K	-8.18 K	7.42	7.45	11.8	14.8	-21.7	-22.7	-466	-635	-343	-322	-265	-265	-0.034	-0.017
Price To Operating Cash Flows Ratio, P/OCF	757	18.2 K	11.3	19.7	13.3	11.1	16.7	9.62	3.61	7.34	-	4.63 K	-16.8 K	-7.24 K	-8.58 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Price Cash Flow Ratio, P/CF	757	18.2 K	11.3	19.7	13.3	11.1	16.7	9.62	3.61	7.34	-	4.63 K	-16.8 K	-7.24 K	-8.58 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Enterprise Value Multiple, EV	92.9	17.2 K	20.9	29.5	9.19	9.17	27.9	17.3	9.91	23.1	7.05	-21.1	6.46	22.8	5.4	-3.67	96.3	8.22	10.8	10.8	23.6	17.8	21.6	27.7	25.9	12	12	-	1.43
Price Fair Value, P/FV	1.01	0.582	0.632	0.588	0.767	0.541	0.419	0.357	0.379	0.322	0.346	0.345	0.256	0.211	0.239	0.247	0.236	0.184	0.236	0.222	0.229	0.816	1.12	1.65	1.6	1.71	1.9	-	0.0

Alle Zahlen in RUB-Währung

Multiplikatoren sind ein wichtiges Instrument der Finanzanalyse für das Unternehmen Завод ДИОД, das es Investoren und Analysten ermöglicht, den Unternehmenswert und die Investitionsattraktivität schnell anhand des Verhältnisses von Marktindikatoren zu den finanziellen Ergebnissen des Unternehmens zu bewerten. Im Wesentlichen drücken Multiplikatoren aus, wie der Markt das Unternehmen im Verhältnis zu seinem Gewinn, Umsatz, Eigenkapital oder anderen wichtigen Kennzahlen bewertet.

Vorteile der Verwendung von Finanzkennzahlen

Vereinfachte Datenanalyse
Finanzkennzahlen verwandeln große Mengen an Buchhaltungsdaten in kompakte und leicht interpretierbare Indikatoren, was die Beurteilung des Unternehmenszustands erheblich vereinfacht.
Vergleichbarkeit zwischen Unternehmen
Multiplikatoren standardisieren Finanzkennzahlen und ermöglichen so einen objektiven Vergleich von Unternehmen unterschiedlicher Größe, Branche und Marktkapitalisierung.
Erkennung von Trends und Problemen
Die regelmäßige Analyse von Kennzahlen hilft, die Entwicklung der finanziellen Gesundheit zu verfolgen, Stärken und Schwächen des Geschäfts sowie potenzielle Risiken zu identifizieren.
Entscheidungsunterstützung
Finanzielle Multiplikatoren dienen Investoren, Gläubigern und der Unternehmensführung als wichtiges Instrument bei Investitions-, Kredit- und Managemententscheidungen.
Beschleunigte Bewertung der Investitionsattraktivität
Mit Hilfe von Kennzahlen können schnell wichtige Leistungs-, Liquiditäts- und Finanzstabilitätsindikatoren bestimmt werden, was eine zügige Bewertung der Attraktivität von Unternehmen für Investitionen ermöglicht.

Die Verwendung von Multiplikatoren ermöglicht den Vergleich von Unternehmen, auch wenn sie sich in Größe oder Branche unterscheiden, da sie Finanzdaten in für die Analyse geeignete Kennzahlen standardisieren. Dies ist besonders nützlich zur Bewertung von Unternehmen, bei denen eine direkte Analyse der Finanzberichte komplex sein kann oder tiefgehendes Fachwissen erfordert.

Finanzkennzahlen anderer Aktien in der Pharmaeinzelhändler

Name	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	-	2.43 %	$ 254 M	Germany
Aptorum Group Limited APM	$ 0.82	-3.48 %	$ 4.47 M	China
Rigel Pharmaceuticals RIGL	$ 33.23	-4.03 %	$ 584 M	USA
Graybug Vision GRAY	-	-11.23 %	$ 9.65 M	USA
I-Mab IMAB	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	-	-	$ 40.3 B	USA
Acer Therapeutics ACER	-	2.71 %	$ 14 M	USA
Biophytis SA BPTS	-	-13.47 %	$ 169 M	France
Ampio Pharmaceuticals AMPE	-	-11.43 %	$ 502 K	USA
Apellis Pharmaceuticals APLS	$ 20.15	-2.68 %	$ 2.54 B	USA
AbCellera Biologics ABCL	$ 3.72	-2.75 %	$ 1.11 B	Canada
Athersys ATHX	-	3.77 %	$ 22.4 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	-	-18.52 %	$ 27.3 M	Britain
AVEO Pharmaceuticals AVEO	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	$ 163.7	-1.61 %	$ 8.14 B	USA
BridgeBio Pharma BBIO	$ 64.66	-1.37 %	$ 12.4 B	USA
Brainstorm Cell Therapeutics BCLI	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	-	-4.8 %	$ 255 M	USA
Burford Capital Limited BUR	$ 8.52	-2.46 %	$ 1.39 B	Britain
Adverum Biotechnologies ADVM	-	-	$ 86.2 M	USA
CymaBay Therapeutics CBAY	-	-	$ 3.45 B	USA
Институт стволовых клеток человека ISKJ	-	-	-	Russia
Avid Bioservices CDMO	-	-	$ 789 M	USA
Certara CERT	$ 7.16	1.49 %	$ 1.15 B	USA
ARCA biopharma ABIO	-	1052.0 %	$ 415 M	USA
Checkpoint Therapeutics CKPT	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	-	-16.75 %	$ 25.8 M	USA
Alpine Immune Sciences ALPN	-	-	$ 2.17 B	USA
Clovis Oncology CLVS	-	-7.23 %	$ 13 M	USA
Acorda Therapeutics ACOR	-	-24.86 %	$ 820 K	USA
Checkmate Pharmaceuticals CMPI	-	-	$ 231 M	USA
Capricor Therapeutics CAPR	$ 25.91	-3.56 %	$ 694 M	USA
Catalyst Pharmaceuticals CPRX	$ 24.0	0.5 %	$ 2.93 B	USA
Acasti Pharma ACST	-	4.01 %	$ 150 M	Canada
Codexis CDXS	$ 0.99	-3.28 %	$ 72.7 M	USA
Corvus Pharmaceuticals CRVS	$ 17.75	-0.79 %	$ 852 M	USA
CTI BioPharma Corp. CTIC	-	-	$ 1.2 B	USA
CohBar CWBR	-	-15.44 %	$ 2.2 M	USA
Cyclacel Pharmaceuticals CYCC	-	-5.98 %	$ 34.1 M	USA
Cyclacel Pharmaceuticals CYCCP	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	-	-	$ 2.18 B	USA
CureVac N.V. CVAC	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	-	5.93 %	$ 314 M	Canada
Denali Therapeutics DNLI	$ 20.02	-4.67 %	$ 3.29 B	USA
AgeX Therapeutics AGE	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-	-	$ 1.01 B	USA
Eton Pharmaceuticals ETON	$ 17.54	-3.36 %	$ 450 M	USA
Entasis Therapeutics Holdings ETTX	-	-	$ 105 M	USA
Evofem Biosciences EVFM	-	7.55 %	$ 38.1 M	USA

Завод ДИОД Kennzahlen 2007-2026 | DIOD

Kennzahlen Jährlich Завод ДИОД

Price Earnings Ratio, P/E

Price Sales Ratio, P/S

Price To Book Ratio, P/B

Price Earnings To Growth Ratio, PEG

Operating Cash Flow Per Share

Free Cash Flow Per Share

Cash Per Share

Payout Ratio

Dividend Yield

Current Ratio

Quick Ratio

Cash Ratio

Days Of Sales Outstanding, DSO

Days Of Inventory Outstanding, DIO

Days Of Payables Outstanding, DPO

Operating Cycle

Cash Conversion Cycle

Gross Profit Margin

Operating Profit Margin

Pretax Profit Margin

Net Profit Margin

Effective Tax Rate

Return On Assets, ROA

Return On Equity, ROE

Return On Capital Employed, ROCE

Net Income Per Ebt

Ebt Per Ebit

Ebit Per Revenue

Debt Ratio

Debt Equity Ratio

Long Term Debt To Capitalization

Total Debt To Capitalization

Interest Coverage

Cash Flow To Debt Ratio

Company Equity Multiplier

Receivables Turnover

Payables Turnover

Inventory Turn Over

Fixed Asset Turnover

Asset Turnover

Operating Cash Flow Sales Ratio

Free Cash Flow Operating Cash Flow Ratio

Cash Flow Coverage Ratios

Short Term Coverage Ratios

Capital Expenditure Coverage Ratio

Dividend Paid And Capex Coverage Ratio

Dividend Payout Ratio

Price To Free Cash Flows Ratio, P/FCF

Price To Operating Cash Flows Ratio, P/OCF

Price Cash Flow Ratio, P/CF

Enterprise Value Multiple, EV

Price Fair Value, P/FV